Aurobindo Pharma receives 6 observations from USFDA for its Unit-3 plant in Hyderabad
On Wednesday, Aurobindo Pharma has said that it has received a Form 483 with six observations from United States Food and Drug Administration (US FDA)...
Download Unicorn Signals App
Powered By EquityPandit
